$15.57
-1.59-9.27%
Last update: Nov 6, 7:46 AM
Ultragenyx Pharmaceutical Inc
RARENASDAQ
The average analyst price target for Ultragenyx Pharmaceutical is $46.19, 196.7% above the current price. Of 20 analysts, 13 rate it Buy and 7 Hold. Targets range from $16 to $140. The latest change came on Nov 5, 2026, when Citigroup lowered its price target on Ultragenyx Pharmaceutical from $32 to $22 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
